Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck: a phase II trial of the Sarah Cannon oncology research consortium.
Hainsworth JD, Spigel DR, Greco FA, Shipley DL, Peyton J, Rubin M, Stipanov M, Meluch A. Hainsworth JD, et al. Cancer J. 2011 Sep-Oct;17(5):267-72. doi: 10.1097/PPO.0b013e3182329791. Cancer J. 2011. PMID: 21952273 Clinical Trial.
Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD, Meluch AA, McClurkan S, Gray JR, Stroup SL, Burris HA 3rd, Yardley DA, Bradof JE, Yost K, Ellis JK, Greco FA. Hainsworth JD, et al. Among authors: meluch aa. Cancer J. 2002 Jul-Aug;8(4):311-21. doi: 10.1097/00130404-200207000-00007. Cancer J. 2002. PMID: 12184409 Clinical Trial.
Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA, Greco FA, Gray JR, Thomas M, Sutton VM, Davis JL, Kalman LA, Shaffer DW, Yost K, Rinaldi DA, Hainsworth JD. Meluch AA, et al. Cancer J. 2003 Jul-Aug;9(4):251-60. doi: 10.1097/00130404-200307000-00007. Cancer J. 2003. PMID: 12967135 Clinical Trial.
Weekly docetaxel/estramustine phosphate in patients with increasing serum prostate- specific antigen levels after primary treatment for prostate cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD, Meluch AA, Spigel DR, Yost K, Meng C, Greco FA. Hainsworth JD, et al. Among authors: meluch aa. Clin Genitourin Cancer. 2006 Mar;4(4):287-92. doi: 10.3816/CGC.2006.n.009. Clin Genitourin Cancer. 2006. PMID: 16729913 Clinical Trial.
23 results